Aug 14, 2015
5:2
For every 2 shares held, investors received 5. The price per share adjusted from $63.00 to $25.20.
The split itself did not change the total investment value.
Lanzhou Foci Pharmaceutical Co., Ltd. Class A (SZSE:002644) operates in the Pharmaceuticals: other industry.
Lanzhou Foci Pharmaceutical Co., Ltd. Class A company overviewLanzhou Foci Pharmaceutical Co., Ltd. Class A's most recent stock split was on August 14, 2015. It was a 5-for-2 forward split, so shareholders received 5 shares for every 2 they held.
Lanzhou Foci Pharmaceutical Co., Ltd. Class A (SZSE:002644) has split its stock 3 times: a 11-for-10 split on June 6, 2012, a 2-for-1 split on May 21, 2014, and a 5-for-2 split on August 14, 2015.
Lanzhou Foci Pharmaceutical Co., Ltd. Class A has split its stock 3 times. This history records 3 forward splits between June 6, 2012 and August 14, 2015.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Lanzhou Foci Pharmaceutical Co., Ltd. Class A's 5-for-2 split on August 14, 2015, every 2 shares became 5 shares.
Lanzhou Foci Pharmaceutical Co., Ltd. Class A has not announced a new split in our records. Its most recent split was on August 14, 2015, 11 years ago. Companies announce splits in advance, and any new SZSE:002644 split will appear on this page.
Already premium?